Reposted by Barral Lab
CD1d remodels the tumor-infiltrating myeloid populations controlling anti-tumor immunity. From Lauren Evans, Maria Conde Poole, Patricia Barral @barrallab.bsky.social: rupress.org/jem/article/...
Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia